Study Group: Neonatal-Perinatal Physicians (US)(?)

Children have long been therapeutic orphans, often relying on off-label use of new drugs which have only been tested on adults. This legislation seeks to remedy that inequality, by encouraging pharmaceutical companies to do more testing in pediatric populations.

With Abbott being such a major player in the infant formula market, will this lead to more promotion of statins in the pediatric office, especially given the recent (although controversial) recommendation for possible statin use in children as young as 8 years old? And since they are involved in the...

Cervical cancer is real, and has the potential to cause significant morbidity and mortality. Yet the incidence in developed countries is relatively small, when compared with the developing world. There is a real, although small, benefit in the US, and while the vaccine is effective, the cost per prevented...

Finally, a recommendation that an available test and treatment NOT be used, under circumstances where there is little to be gained and much to be lost.

Just like expensive, do-everything end-of-life care, like unlimited imaging studies, like newest drugs, patients want it all. This is one of the attitudes which causes the US to spend far more than other developed countries for far less efficient and cost-effective health care.